2813334-66-4

2813334-66-4 structure
2813334-66-4 structure
  • Name: hCAIX-IN-13
  • Chemical Name: hCAIX-IN-13
  • CAS Number: 2813334-66-4
  • Molecular Formula: C37H33F3N6O7PtS2
  • Molecular Weight: 989.90
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2022-11-22 01:44:59
  • Modify Date: 2025-08-25 19:42:35
  • hCAIX-IN-13 (Pt2) is an inhibitor of CAIX (arbonic anhydrase IX) with an IC50 value of 6.57 μM. hCAIX-IN-13 inhibits growth of cancer cells and induces cell apoptosis, it can be used for the research of cancer[1].

Name hCAIX-IN-13
Description hCAIX-IN-13 (Pt2) is an inhibitor of CAIX (arbonic anhydrase IX) with an IC50 value of 6.57 μM. hCAIX-IN-13 inhibits growth of cancer cells and induces cell apoptosis, it can be used for the research of cancer[1].
Related Catalog
Target

IC50: 6.57 μM (CAIX)[1]

In Vitro hCAIX-IN-13 (10 and 20 μM; 24 h) effectively attenuates extracellular acidification through the inhibited activity of the cellular CAIX expression[1]. hCAIX-IN-13 (20 and 40 μM; 24 h) affects CAIX expression[1]. hCAIX-IN-13 (0-200 μM; 24 h) shows high cytotoxicity to cancer cell lines[1]. hCAIX-IN-13 (5-15 μM; 24 h) promotes the production of cellular ROS[1]. hCAIX-IN-13 (5-20 μM; 48 h) induces cell apoptosis[1]. Western Blot Analysis[1] Cell Line: MDA-MB-231 cell line Concentration: 20 and 40 μM Incubation Time: 24 hours Result: Dose-dependently inhibited the expression level of cellular CAIX. Cell Cytotoxicity Assay[1] Cell Line: Hela, A549, MDA-MB 231, HLF and LO2 cell lines Concentration: 0-200 μM Incubation Time: 48 hours Result: Showed cytotoxicity to Hela, A549, MDA-MB 231, normal cell HLF and normal cell LO2 with IC50s of 31.64, 30.45, 12.67, 21.64 and >100 μM, respectively. Apoptosis Analysis[1] Cell Line: MDA-MB-231 cell line Concentration: 5-20 μM Incubation Time: 48 hours Result: Dose-dependently induced the early apoptotic stage.
References

[1]. Yang J, et al. NIR phosphorescent cyclometalated platinum (II) complexes with CAIX targeted and nuclear penetration as potent anticancer theragnostic agents. Eur J Med Chem. 2022 Aug 31;243:114702.

Molecular Formula C37H33F3N6O7PtS2
Molecular Weight 989.90
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.